BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3603588)

  • 1. Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat.
    Bhargava HN
    Toxicol Lett; 1987 Jul; 37(2):135-41. PubMed ID: 3603588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK; Lai JC; Lim L
    Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain.
    Kajiyama H; Nomura Y
    J Pharmacobiodyn; 1981 Feb; 4(2):85-90. PubMed ID: 7196947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
    Sanvarinda Y; Phivthongngam L; Govitrapong P
    Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
    Suga M
    Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
    [No Abstract]   [Full Text] [Related]  

  • 6. Manganese toxicity: muscarinic receptor binding in the mouse brain.
    Villalobos V; Castro F; Bonilla E; Estévez J; Dávila JO
    J Toxicol Environ Health; 1994 Jun; 42(2):185-91. PubMed ID: 8207754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H; Hashimoto T; Kuriyama K
    Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment.
    Koide T; Matsushita H
    Life Sci; 1981 Mar; 28(10):1139-45. PubMed ID: 7231043
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain.
    Lim DK; Ito Y; Hoskins B; Ho IK
    Brain Res Bull; 1988 Jul; 21(1):21-4. PubMed ID: 3064880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL; Dawson TM; Wamsley JK
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN; Perlow MJ
    Toxicol Lett; 1988 Mar; 40(3):219-24. PubMed ID: 3258448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitters and neurotransmitter receptors in developing and adult rats during manganese poisoning.
    Seth PK; Chandra SV
    Neurotoxicology; 1984; 5(1):67-76. PubMed ID: 6144084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J; Syvälahti E; Röyttä M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.
    Giménez R; Raïch J; Aguilar J
    Br J Pharmacol; 1991 Nov; 104(3):575-8. PubMed ID: 1839138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and cholinergic muscarinic receptor effects of L-alphacetylmethadol (LAAM) and its metabolites.
    Langley AE; Smith SG; Zeid RL
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):350-5. PubMed ID: 6463046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.